Guardant Health (GH) Competitors

Guardant Health (NASDAQ:GH) and Natera (NASDAQ:NTRA) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, community ranking, valuation and risk.

Which has more risk & volatility, GH or NTRA?

Guardant Health has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500.

Do analysts prefer GH or NTRA?

Guardant Health presently has a consensus price target of $48.40, suggesting a potential upside of 4.18%. Natera has a consensus price target of $178.12, suggesting a potential upside of 15.23%. Given Natera's higher possible upside, analysts clearly believe Natera is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	0 Sell rating(s)	0 Hold rating(s)	20 Buy rating(s)	0 Strong Buy rating(s)	3.00
Natera	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community favor GH or NTRA?

Natera received 197 more outperform votes than Guardant Health when rated by MarketBeat users. However, 70.94% of users gave Guardant Health an outperform vote while only 68.92% of users gave Natera an outperform vote.

Company	Underperform	Outperform
Guardant Health	Outperform Votes 293 70.94%	Underperform Votes 120 29.06%
Natera	Outperform Votes 490 68.92%	Underperform Votes 221 31.08%

Which has preferable earnings and valuation, GH or NTRA?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$739.02M	7.76	-$479.45M	-$3.56	-13.05
Natera	$1.70B	12.31	-$434.80M	-$1.53	-101.03

Does the media prefer GH or NTRA?

In the previous week, Natera had 17 more articles in the media than Guardant Health. MarketBeat recorded 25 mentions for Natera and 8 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.99 beat Natera's score of 0.98 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Natera	16 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is GH or NTRA more profitable?

Natera has a net margin of -14.01% compared to Guardant Health's net margin of -59.05%. Natera's return on equity of -26.23% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-59.05%	-19,157.20%	-25.96%
Natera	-14.01%	-26.23%	-14.27%

Do institutionals and insiders hold more shares of GH or NTRA?

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 5.5% of Guardant Health shares are owned by company insiders. Comparatively, 7.6% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Natera beats Guardant Health on 13 of the 17 factors compared between the two stocks.